The US patients were part of an NIMH-funded Clinical Research Center at Case Western Reserve University and prospective clinical trials at Vanderbilt University. Information about recruitment and assessment has been previously reported [55],[56]. The healthy controls were recruited as part of the Genetics of Memory/ Genetics of Epilepsy studied at Duke. All subjects were cognitively normal and free of neuropsychiatric disorders.
